The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis
- 27 October 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 17 (12), 1290-1293
- https://doi.org/10.1038/s41423-020-00566-8
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31871404)
This publication has 9 references indexed in Scilit:
- Association between pathological and MRI findings in multiple sclerosisLancet Neurology, 2019
- RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased ProgramsImmunity, 2018
- Multiple sclerosisThe Lancet, 2018
- Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosisJournal of Autoimmunity, 2018
- Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren’s syndromeCellular & Molecular Immunology, 2017
- Pathogenesis of multiple sclerosis: insights from molecular and metabolic imagingThe Lancet Neurology, 2014
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- Interleukin-17 and its expanding biological functionsCellular & Molecular Immunology, 2010
- Chronological Changes of CD4+ and CD8+ T Cell Subsets in the Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple SclerosisThe Tohoku Journal of Experimental Medicine, 2007